Trial Profile
A Phase 3 Multicenter, Open Label, Randomized Study of XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors Not Amenable to Conventional Surgery
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 02 Sep 2021
Price :
$35
*
At a glance
- Drugs Becatecarin (Primary) ; Fluorouracil; Folic acid
- Indications Biliary cancer
- Focus Registrational; Therapeutic Use
- Sponsors Exelixis; Helsinn
- 02 Sep 2021 This trial has been completed in Spain, according to European Clinical Trials Database.
- 21 Nov 2012 New source identified and integrated (German Clinical Trials Register, DRKS00004071).
- 13 Jan 2009 Added actual trial completion date, as reported by ClinicalTrials.gov.